Asian equities ended the week mixed, led higher by Hong Kong, especially Hong Kong-listed growth stocks, while Taiwan underperformed.

Asian equities were mostly lower overnight as Pakistan and Thailand outperformed and Hong Kong and Indonesia underperformed.

China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed ...

Background Cardiovascular disease (CVD) remains a significant public health challenge in China. This study aimed to project ...

Breast cancer remains a major global health challenge, with treatment strategies varying widely across regions.

President Donald Trump's tariffs on China have raised significant concern over their potential impact on healthcare costs, but while the move could have a broad effect on the industry, it is ...

Potential impacts of the tariffs include higher prices for drugs and medical supplies, and possible shortages.

A 10% tariff on goods from China, and proposed 25% tariffs on goods from Mexico and Canada, is jolting a healthcare industry that relies heavily on imported medical devices and supplies.

Exclusive travel for senior citizens! China’s medical-equipped silver tourist trains to revolutionise tourism for ageing boomers.

SHANGHAI: China's healthcare regulator on Sunday (Feb 9) defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals, saying an ...